|
VPS4B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.55330000037613E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.89539999999599E-05 |
| Normal-vs-Stage2 |
2.581200E-04 |
| Normal-vs-Stage3 |
2.09449999999389E-06 |
| Normal-vs-Stage4 |
2.56440000012681E-07 |
| Stage1-vs-Stage2 |
6.506800E-01 |
| Stage1-vs-Stage3 |
3.017800E-01 |
| Stage1-vs-Stage4 |
6.844200E-02 |
| Stage2-vs-Stage3 |
7.802000E-01 |
| Stage2-vs-Stage4 |
2.809400E-01 |
| Stage3-vs-Stage4 |
3.368600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.56919999952876E-07 |
| Normal-vs-AfricanAmerican |
3.293800E-02 |
| Normal-vs-Asian |
2.623200E-04 |
| Caucasian-vs-AfricanAmerican |
2.756200E-01 |
| Caucasian-vs-Asian |
9.746000E-01 |
| AfricanAmerican-vs-Asian |
3.568000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.91559999979307E-08 |
| Normal-vs-Female |
1.51076000000083E-05 |
| Male-vs-Female |
9.346000E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.048540E-04 |
| Normal-vs-Age(41-60Yrs) |
1.09429999994859E-06 |
| Normal-vs-Age(61-80Yrs) |
8.29219999998188E-07 |
| Normal-vs-Age(81-100Yrs) |
1.596390E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.274200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.312200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.424800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.973400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.690000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.817200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.638600E-01 |
| Classical-VS-Follicular |
4.363000E-03 |
| Classical-VS-Other |
5.924200E-02 |
| Classical-VS-Normal |
8.05080000000347E-05 |
| Tall-VS-Follicular |
5.064200E-01 |
| Tall-VS-Other |
1.875800E-01 |
| Tall-VS-Normal |
3.024700E-04 |
| Follicular-VS-Other |
4.141400E-01 |
| Follicular-VS-Normal |
4.18389999978785E-07 |
| Other-VS-Normal |
1.102600E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.35650000021981E-07 |
| Normal-vs-N1 |
1.45370000004252E-06 |
| N0-vs-N1 |
2.663200E-01 |
|
|
